September 30, 2021
Unique five-year agreement will help Philadelphia-based health
leader integrate and standardize innovative cardiovascular care,
helping to deliver on the quadruple aim
Amsterdam, the Netherlands and Philadelphia, PA
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, and Lankenau Heart Institute part of Main Line
Health, today announced they have entered a five-year strategic
partnership focused on integrated cardiovascular solutions. Working
together, Philips and Main Line Health will develop an ecosystem of
clinically-enabled cardiovascular solutions that will allow Main
Line Health to standardize and integrate technology across its
network, helping to unlock patient data for better clinical
decisions, while optimizing workflows for a better patient and
staff experience. In addition, the partnership aims to help Main
Line Health drive predictability and consistency in costs, as well
as focus on clinical and technical training.
Providing care to the Philadelphia region and its western
suburbs, Main Line Health is committed to delivering advanced
medicine to treat and cure disease, while also playing an important
role in prevention strategies and disease management. At its core
are four of the region’s most respected acute care hospitals –
Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and
Riddle Hospital. Moreover, Main Line Health conducts clinical
research in the latest health care innovations and trains
physicians and other health care providers to ensure its staff can
provide the best, most advanced care to the communities they
serve.
“Through this innovative business model, we will have a
technology partner who can help us adopt the solutions that will
not only help us drive operational efficiency, they will allow us
to expand the type of quality care our patients have come to
expect,” said Trudy Mazzone, MS, BSRT, (R), System Director, Main
Line Health Cardiovascular Services and Co-director, Lankenau Heart
Institute.
“By partnering with Philips, we will be able to continue our
world-class cardiovascular care system-wide, including fully
renovating and installing state-of-the-art Philips equipment to
provide advanced cardiovascular and neuro care at Bryn Mawr
Hospital and Paoli Hospital,” said William Gray, MD, System Chief,
Cardiovascular Diseases, Main Line Health and Co-director, Lankenau
Heart Institute. “This will allow us to define a strategy for the
future, adopting novel technology as it evolves.”
This long-term strategic partnership will uniquely focus on
integrated cardiovascular solutions. As part of the partnership, a
dedicated team of Philips solutions architects will work
collaboratively with Main Line Health to understand their
challenges and develop technology plans around the cardiovascular
service line. These technology plans are tailored to their needs
with three objectives in mind: clinical, operational and business
model innovation.
Philips brings over a century of experience in healthcare,
providing best practices in world class facility planning and
design, intelligent technology implementation, data analytics and
IT integration, and education management, as well as workflow and
performance optimization.
“Healthcare technology is evolving at a rapid rate and
partnering with Main Line Health will allow us to understand
patient needs and workflows, map them to the right solutions and
help them to deliver on the quadruple aim,” said Vitor Rocha,
Market Leader for Philips North America. “Together we can help them
keep pace with technology, allowing them to focus on what is most
important: providing high quality care, positive patient outcomes
and a superior patient experience for their community.”
William Gray has a consulting relationship with Philips.
For further information, please contact:
PhilipsSilvie CasanovaPhilips North AmericaTel:
+1 781 879 0692silvie.casanova@philips.com
Joost MalthaPhilips Global Press OfficeTel: +31 610 558
116Email: joost.maltha@philips.com
Main Line HealthSamantha KrouseManager,
CommunicationsTel: +1 484 580 1059Krouses@mlhs.org
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being, and enabling better
outcomes across the health continuum – from healthy living and
prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer
insights to deliver integrated solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2020
sales of EUR 17.3 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
About Lankenau Heart InstituteThe Lankenau
Heart Institute is Main Line Health’s premier, comprehensive
cardiovascular medicine and surgery program. The Lankenau Heart
Institute brings together the clinical expertise of all four Main
Line Health acute care hospitals and community cardiology practices
to ensure that patients receive a level of quality, service, and
experience that is unprecedented in the region. Through the
system-wide coordination of services, the Lankenau Heart Institute
delivers preventive, diagnostic, therapeutic, and rehabilitative
cardiovascular services at each of our locations including Lankenau
Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle
Hospital.
Lankenau Heart Institute continues to be a pioneer in the use of
beating-heart techniques and robotic-assisted procedures for
coronary artery revascularization, minimally invasive and
transcatheter approaches for valve repair and replacement, and
complex aortic surgeries. With our growing experience and focus on
minimally invasive techniques, Lankenau Heart Institute has
expanded participation in clinical trials year over year. Our
physicians are frequently invited to participate in
clinical/medical device trials, many of these designed to
facilitate minimally invasive procedures/approaches.
With a collaborative team of expert consultative cardiologists,
interventional cardiologists, electrophysiologists, cardiovascular
surgeons and specially trained nurses and technologists, the
Lankenau Heart Institute is dedicated to managing and treating
patients with heart failure, aortic disease, coronary and
peripheral vascular disease, heart rhythm disorders and valve
disease. Our team of cardiologists and cardiac specialists provide
patients and their families with expert cardiac care, close to
home.
About Main Line HealthFounded in 1985, Main
Line Health is a not-for-profit health system serving portions of
Philadelphia and its western suburbs. Main Line Health’s
commitment—to deliver advanced medicine to treat and cure disease
while also playing an important role in prevention and disease
management as well as training physicians and other health care
providers—reflects our intent to keep our community and ourselves
well ahead. A team of more than 10,000 employees and 2,000
physicians care for patients throughout the Main Line Health
system.
At Main Line Health’s core are four of the region’s most
respected acute care hospitals—Lankenau Medical Center, Bryn Mawr
Hospital, Paoli Hospital and Riddle Hospital—as well as one of the
nation’s recognized facilities for rehabilitative medicine, Bryn
Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug
and alcohol recovery; Main Line Health HomeCare & Hospice,
which includes skilled home health care, hospice and home infusion
services; Main Line Health Centers, primary and specialty care, lab
and radiology, and other outpatient services located in Broomall,
Collegeville, Concordville, Exton, King of Prussia and Newtown
Square; Lankenau Institute for Medical Research, a biomedical
research organization; and Main Line HealthCare, one of the
region’s largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality
care and service, including System Magnet® designation, the
nation’s highest distinction for nursing excellence and the
Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence
Award. Main Line Health is committed to creating an environment of
diversity, respect and inclusion and has proudly embraced the
American Hospital Association’s #123forEquity Pledge to Act to
eliminate disparities in care. We are dedicated to advancing
patient-centered care, education and research to help our community
stay healthy.
- Lankenau Heart Institute, part of Main Line Health
- Case review at Lankenau Heart Institute
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Sep 2023 to Sep 2024